ECSP17045428A - Nuevos virus de tilapia y sus usos - Google Patents
Nuevos virus de tilapia y sus usosInfo
- Publication number
- ECSP17045428A ECSP17045428A ECIEPI201745428A ECPI201745428A ECSP17045428A EC SP17045428 A ECSP17045428 A EC SP17045428A EC IEPI201745428 A ECIEPI201745428 A EC IEPI201745428A EC PI201745428 A ECPI201745428 A EC PI201745428A EC SP17045428 A ECSP17045428 A EC SP17045428A
- Authority
- EC
- Ecuador
- Prior art keywords
- tilv
- relates
- nucleic acid
- acid sequences
- isolated
- Prior art date
Links
- 241000276707 Tilapia Species 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title abstract 2
- 241001601305 Tilapia lake virus Species 0.000 abstract 6
- 150000007523 nucleic acids Chemical group 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000009368 gene silencing by RNA Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La invención se dirige al Virus de la Tilapia del Lago aislado o TiLV, y las secuencias y polipéptidos de ácido nucleico aislado del mismo. La invención también se refiere a sondas y cebadores, y a anticuerpos contra antígenos del TiLV, y el uso de estos reactivos para detectar la presencia o ausencia de TiLV en un animal. La invención también se refiere a ARNis que se dirigen a secuencias de ácido nucleico de TiLV. La invención también se refiere a composiciones inmunogénicas, incluyendo anticuerpos y vacunas, para inducir una respuesta inmune contra TiLV en un animal. La invención también se refiere a construcciones genéticas y células que comprenden TiLV y secuencias de ácidos nucleicos aislados y polipéptidos de las mismas para su uso en el desarrollo de agentes profilácticos y terapéuticos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462091824P | 2014-12-15 | 2014-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP17045428A true ECSP17045428A (es) | 2018-07-31 |
Family
ID=56127461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201745428A ECSP17045428A (es) | 2014-12-15 | 2017-07-14 | Nuevos virus de tilapia y sus usos |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US10183072B2 (es) |
| CN (2) | CN107427570A (es) |
| BR (1) | BR112017012852A2 (es) |
| CO (1) | CO2017007105A2 (es) |
| CR (1) | CR20210528A (es) |
| EC (1) | ECSP17045428A (es) |
| HK (1) | HK1244700A1 (es) |
| IL (3) | IL266234B2 (es) |
| MX (3) | MX371220B (es) |
| MY (3) | MY208671A (es) |
| SG (3) | SG10202102695UA (es) |
| WO (1) | WO2016100328A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL230970A0 (en) | 2014-02-13 | 2014-09-30 | Univ Ramot | Tilapia virus vaccines |
| WO2017118989A1 (en) * | 2016-01-10 | 2017-07-13 | Kovax Ltd. | Orthomyxo-like virus of tilapia |
| CN108018377B (zh) * | 2017-12-07 | 2021-07-20 | 中国水产科学研究院珠江水产研究所 | 一种罗湖病毒的rt-lamp检测引物组、试剂盒及方法 |
| CN108018378A (zh) * | 2017-12-11 | 2018-05-11 | 中国水产科学研究院珠江水产研究所 | 一种罗湖病毒Taq-man探针荧光定量PCR检测试剂盒及检测方法 |
| CN108192869A (zh) * | 2018-01-24 | 2018-06-22 | 武汉轻工大学 | 一种斑点叉尾鮰头肾巨噬细胞原代分离培养方法及应用 |
| CN108220483A (zh) * | 2018-02-12 | 2018-06-29 | 深圳出入境检验检疫局动植物检验检疫技术中心 | 一种用于罗非鱼湖病毒检测的试剂、检测方法及应用 |
| CN109234451B (zh) * | 2018-09-26 | 2021-04-16 | 中国水产科学研究院长江水产研究所 | 一种罗非鱼细小病毒TiPV CPA检测引物及应用 |
| CN109852588B (zh) * | 2018-12-24 | 2023-03-07 | 中国水产科学研究院珠江水产研究所 | 一种抗罗非鱼免疫球蛋白IgM的单克隆抗体及其细胞株和应用 |
| CN110616281A (zh) * | 2019-10-29 | 2019-12-27 | 周伟光 | 一种应用实时荧光rt-pcr定量检测罗湖病毒的方法 |
| CN111436390B (zh) * | 2020-04-20 | 2021-11-16 | 中国热带农业科学院热带生物技术研究所 | 一种降低TiLV对罗非鱼致死率的温度调控养殖系统及方法 |
| CN113122510A (zh) * | 2021-04-12 | 2021-07-16 | 中国水产科学研究院黑龙江水产研究所 | 一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法 |
| CN113755645B (zh) * | 2021-09-30 | 2023-06-09 | 厦门海关技术中心 | 一种检测罗湖病毒的荧光定量rt-pcr引物对和探针，试剂盒和检测方法 |
| CN113718061B (zh) * | 2021-09-30 | 2023-06-09 | 厦门海关技术中心 | 一种同时检测罗湖病毒和病毒性神经坏死病毒的双重rt-pcr的引物组，试剂盒和方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| WO2003017780A1 (en) * | 2001-08-27 | 2003-03-06 | Advanced Bionutrition Corporation | Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses |
| WO2003050142A1 (en) * | 2001-12-07 | 2003-06-19 | Schweitzer Chemical Corporation Usa | Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides |
| US8796436B2 (en) * | 2003-04-17 | 2014-08-05 | Alnylam Pharmaceuticals, Inc. | Modified iRNA agents |
| US20090149641A1 (en) | 2007-03-07 | 2009-06-11 | Nofima Akvaforsk-Fiskeriforskning As | Fish disease protection |
| CA2776386C (en) | 2009-10-02 | 2018-02-27 | The Trustees Of Columbia University In The City Of New York | Piscine reovirus immunogenic compositions |
| CA2885333C (en) * | 2012-09-26 | 2021-02-09 | Fvg Limited | Subunit immersion vaccines for fish |
| IL230970A0 (en) | 2014-02-13 | 2014-09-30 | Univ Ramot | Tilapia virus vaccines |
-
2015
- 2015-12-15 IL IL266234A patent/IL266234B2/en unknown
- 2015-12-15 WO PCT/US2015/065795 patent/WO2016100328A1/en not_active Ceased
- 2015-12-15 SG SG10202102695UA patent/SG10202102695UA/en unknown
- 2015-12-15 MY MYPI2022001780A patent/MY208671A/en unknown
- 2015-12-15 MY MYPI2017702170A patent/MY176597A/en unknown
- 2015-12-15 CN CN201580073920.9A patent/CN107427570A/zh active Pending
- 2015-12-15 US US15/536,325 patent/US10183072B2/en active Active
- 2015-12-15 MX MX2017007876A patent/MX371220B/es active IP Right Grant
- 2015-12-15 HK HK18104276.7A patent/HK1244700A1/zh unknown
- 2015-12-15 SG SG10201901053TA patent/SG10201901053TA/en unknown
- 2015-12-15 SG SG11201704887SA patent/SG11201704887SA/en unknown
- 2015-12-15 CN CN202111091381.5A patent/CN114057841A/zh active Pending
- 2015-12-15 IL IL252919A patent/IL252919B/en unknown
- 2015-12-15 MY MYPI2019004881A patent/MY192642A/en unknown
- 2015-12-15 CR CR20210528A patent/CR20210528A/es unknown
- 2015-12-15 BR BR112017012852-7A patent/BR112017012852A2/pt not_active Application Discontinuation
- 2015-12-15 IL IL286265A patent/IL286265B2/en unknown
- 2015-12-15 MX MX2018013582A patent/MX382985B/es unknown
-
2017
- 2017-06-14 MX MX2021002525A patent/MX392857B/es unknown
- 2017-07-14 CO CONC2017/0007105A patent/CO2017007105A2/es unknown
- 2017-07-14 EC ECIEPI201745428A patent/ECSP17045428A/es unknown
-
2018
- 2018-08-23 US US16/110,432 patent/US10596249B2/en active Active
-
2020
- 2020-02-06 US US16/783,597 patent/US10973902B2/en active Active
-
2021
- 2021-03-05 US US17/193,583 patent/US11583579B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017007105A2 (es) | Nuevos virus de tilapia | |
| BR112017008165A2 (pt) | anticorpos de domínio único direcionados contra antígenos intracelulares | |
| EA201890999A1 (ru) | Вакцина против вируса простого герпеса | |
| BR112013020070A8 (pt) | moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas | |
| CL2018000432A1 (es) | Vacunas terapéuticas contra el hpv18 | |
| CN106714826A8 (zh) | 用于减弱基因表达调节抗病毒转移载体免疫应答的方法和组合物 | |
| MX2023006203A (es) | Vacunas novedosas contra el virus de zika. | |
| MX2017005159A (es) | Composiciones y metodos para detectar un virus de rna. | |
| AR102547A1 (es) | Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso | |
| AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
| MX2017008096A (es) | Pestivirus. | |
| MX381211B (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| MX377258B (es) | Composiciones de vectores poxvirus y su uso para inducir una respuesta inmunitaria. | |
| EP3939604A3 (en) | Influenza hemagglutinin protein vaccines | |
| MX382530B (es) | Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos. | |
| MX383506B (es) | Parvovirus porcino. | |
| BR112018014042A2 (pt) | vírus do tipo orthomyxo da tilápia. | |
| BR112018008840A2 (pt) | anticorpos de domínio único direcionados contra antígenos intracelulares | |
| BR112014020025A8 (pt) | Vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas | |
| CO7461135A2 (es) | Parvovirus porcino 5b, métodos de uso y vacuna | |
| PH12017501100A1 (en) | Recombinant swinepox virus and vaccines | |
| CY1125328T1 (el) | Ανασυνδυασμενο εμβολιο ιου λευχαιμιας αιλουροειδων περιεχοντας βελτιστοποιημενο γονιδιο φακελου ιου λευχαιμιας αιλουροειδων | |
| WO2016022958A3 (en) | Tick-associated virus sequences and uses thereof | |
| AR094846A1 (es) | Proteínas h5 del virus de la gripe h5n1 para uso como un medicamento | |
| MX361804B (es) | Vacunas genéticas contra el virus hendra y el virus nipah. |